tickrz reports
Biogen Inc (BIIB)
Healthcare | Drugs
338.91  0.87%
BIIB vs DRUGS SECTOR & S&P 500
VALUATION
BIIBSECTORS&P 500
P/E RATIO20.4140.521.12
EV/EBITDA RATIO12.39133.412.66
P/S RATIO6.016.52.25
P/B RATIO5.537.73.45
QUALITY
RETURN ON EQUITY27.91%15.79%13.64%
RETURN ON CAPITAL30.26%19.38%10.09%
NET MARGIN36.32%14.46%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATIO8.69%
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
5 OUT OF 9
DEBT-TO-EQUITY51%
INTEREST COVERAGE17.3x
CURRENT RATIO2.19
GROWTH
5 YR EPS GROWTH27.41%
5 YR SPS GROWTH19.33%
5 YR BPS GROWTH16.2%
Biogen Inc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership